Episode 52: A New Trial in Pancreatic Cancer

Episode 55: New Approvals for Breast Cancer

Dr. Virginia Kaklamani joins Healthcare Unfiltered EXPRESS to discuss the recent FDA-approved indications for T-DXd in breast cancer, and what this means for treating patients with the disease. A critical episode ahead of the annual ASCO meeting. Check it out, subscribe, rate, review, and join the conversation.

Episode 54: Updates from ESMO Breast 2026 in Berlin

Dr. Rani Bansal of Duke University joins the show to share her insights on the latest ESMO Breast meeting that concluded in Berlin. Dr. Rani shares data on the top 5 abstracts that may change or inform practice. Check it out, share, subscribe, and join the conversation.

Episode 53: Hantavirus: The Facts

Dr. Emily Landon of the University of Chicago joins the show to explain everything you must know about the Hantavirus - should we be concerned? What to do? What not to do? Is this another COVID? Get the facts right here, and please share, subscribe, and join the conversation.

Episode 52: A New Trial in Pancreatic Cancer

Dr. Deva Mahalingam shares on Healthcare Unfiltered EXPRESS a new paper published in Nature Medicine on a regimen showing significant promise in pancreatic cancer. You want to listen to this podcast and check out the paper. https://www.nature.com/articles/s41591-026-04327-4 [https://www.nature.com/articles/s41591-026-04327-4] Share, subscribe, and join the conversation.

Episode 51: Treating Relapsed/Refractory CLL

Dr. Matt Davids of the Dana Farber Cancer Institute joins Healthcare Unfiltered EXPRESS to share his data-solidified insights on navigating the treatment of relapsed/refractory (R/R) CLL, considering the welcome advances the field has witnessed in treating front-line disease. Check it out, subscribe, rate, and join the conversation.